These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33410127)

  • 1. The cytosolic tryparedoxin peroxidase from Trypanosoma cruzi induces a pro-inflammatory Th1 immune response in a peroxidatic cysteine-dependent manner.
    López L; Chiribao ML; Girard MC; Gómez KA; Carasi P; Fernandez M; Hernandez Y; Robello C; Freire T; Piñeyro MD
    Immunology; 2021 May; 163(1):46-59. PubMed ID: 33410127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection.
    Girard MC; Acevedo GR; López L; Ossowski MS; Piñeyro MD; Grosso JP; Fernandez M; Hernández Vasquez Y; Robello C; Gómez KA
    Immunology; 2018 Nov; 155(3):367-378. PubMed ID: 29972690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryparedoxin peroxidases from Trypanosoma cruzi: high efficiency in the catalytic elimination of hydrogen peroxide and peroxynitrite.
    Piñeyro MD; Arcari T; Robello C; Radi R; Trujillo M
    Arch Biochem Biophys; 2011 Mar; 507(2):287-95. PubMed ID: 21167808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligomerization dynamics and functionality of Trypanosoma cruzi cytosolic tryparedoxin peroxidase as peroxidase and molecular chaperone.
    Piñeyro MD; Arias D; Ricciardi A; Robello C; Parodi-Talice A
    Biochim Biophys Acta Gen Subj; 2019 Oct; 1863(10):1583-1594. PubMed ID: 31265897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.
    Schnapp AR; Eickhoff CS; Sizemore D; Curtiss R; Hoft DF
    Infect Immun; 2002 Sep; 70(9):5065-74. PubMed ID: 12183554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi.
    Hoft DF; Schnapp AR; Eickhoff CS; Roodman ST
    Infect Immun; 2000 Jan; 68(1):197-204. PubMed ID: 10603388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a trypanothione-dependent peroxidase system in Trypanosoma cruzi.
    Lopez JA; Carvalho TU; de Souza W; Flohé L; Guerrero SA; Montemartini M; Kalisz HM; Nogoceke E; Singh M; Alves MJ; Colli W
    Free Radic Biol Med; 2000 Mar; 28(5):767-72. PubMed ID: 10754272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage- and endogenously-derived peroxynitrite.
    Piacenza L; Peluffo G; Alvarez MN; Kelly JM; Wilkinson SR; Radi R
    Biochem J; 2008 Mar; 410(2):359-68. PubMed ID: 17973627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.
    Bryan MA; Guyach SE; Norris KA
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e733. PubMed ID: 20625554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential use of TLR2 and TLR9 in the regulation of immune responses during the infection with Trypanosoma cruzi.
    Gravina HD; Antonelli L; Gazzinelli RT; Ropert C
    PLoS One; 2013; 8(5):e63100. PubMed ID: 23650544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-sialidase overcomes many antigens to be used as a vaccine candidate against Trypanosoma cruzi.
    Bontempi I; Fleitas P; Poato A; Vicco M; Rodeles L; Prochetto E; Cabrera G; Beluzzo B; Arias D; Racca A; Guerrero S; Marcipar I
    Immunotherapy; 2017 Jun; 9(7):555-565. PubMed ID: 28595515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity.
    González-Chávez Z; Vázquez C; Mejia-Tlachi M; Márquez-Dueñas C; Manning-Cela R; Encalada R; Rodríguez-Enríquez S; Michels PAM; Moreno-Sánchez R; Saavedra E
    Redox Biol; 2019 Sep; 26():101231. PubMed ID: 31203195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxiredoxins from Trypanosoma cruzi: virulence factors and drug targets for treatment of Chagas disease?
    Piñeyro MD; Parodi-Talice A; Arcari T; Robello C
    Gene; 2008 Jan; 408(1-2):45-50. PubMed ID: 18022330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of cytosolic and mitochondrial tryparedoxin peroxidase in Trypanosoma cruzi populations susceptible and resistant to benznidazole.
    Nogueira FB; Ruiz JC; Robello C; Romanha AJ; Murta SM
    Parasitol Res; 2009 Mar; 104(4):835-44. PubMed ID: 19018566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi.
    Matos MN; Cazorla SI; Schulze K; Ebensen T; Guzmán CA; Malchiodi EL
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005300. PubMed ID: 28234897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic control analysis of the Trypanosoma cruzi peroxide detoxification pathway identifies tryparedoxin as a suitable drug target.
    González-Chávez Z; Olin-Sandoval V; Rodíguez-Zavala JS; Moreno-Sánchez R; Saavedra E
    Biochim Biophys Acta; 2015 Feb; 1850(2):263-73. PubMed ID: 25450181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection.
    Ouaissi A; Guilvard E; Delneste Y; Caron G; Magistrelli G; Herbault N; Thieblemont N; Jeannin P
    J Immunol; 2002 Jun; 168(12):6366-74. PubMed ID: 12055254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational and oligomeric effects on the cysteine pK(a) of tryparedoxin peroxidase.
    Yuan Y; Knaggs M; Poole L; Fetrow J; Salsbury F
    J Biomol Struct Dyn; 2010 Aug; 28(1):51-70. PubMed ID: 20476795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.